SynthesisJournal of robotic surgery2026
Mapping the evolving trends of robotic surgery in gastric and colorectal cancer: a clinical trial landscape analysis.
Synthesis in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Robotic versus laparoscopic low anterior resection for rectal cancer: an updated systematic review and meta-analysis.Journal of robotic surgery · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Robot-assisted surgery provides important support for the treatment of gastric cancer (GC) and colorectal cancer (CRC) with its minimally invasive advantages. Through a systematic analysis of 188 clinical trials registered on ClinicalTrials.gov, this study aims to synthesize the research landscape in the field, identify evidence gaps, and provide a basis for optimizing clinical practice and guiding the design of future clinical trials. The analysis of 71 interventional trials with robotic surgery as the core intervention shows that the research activity has increased significantly after 2020. China is the main contributor (64.79%), but the international cooperation rate is only 5.63%. The trials was mainly sponsored by organizations (53.52%, n = 38) and universities (32.39%, n = 23). More than half of the trials (53.52%, n = 38) compared robotic surgery with laparoscopic surgery, and the Da Vinci surgical system is the most commonly used platform (n = 29). Primary outcome measures focused on short-term indicators, including complications and adverse events (22.95%) and pathological outcomes (13.93%), while long-term oncological and functional outcomes accounted for a lower proportion (27.87%). This study reveals the key problems of significant geographical concentration dominated by China, lack of international cooperation, and insufficient long-term evidence. In the future, it is necessary to give priority to high-quality multi-center global trials and systematically evaluate long-term results to improve the accuracy and accessibility of robotic surgery in the treatment of gastrointestinal cancer.
Indexed as
Identifiers
41689680What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.